Discover key insights from McKesson’s Q2 2026 earnings call, including record growth, raised guidance, and strategic investments.
McKesson Corp (MCK) reports a 10% revenue increase and raises earnings guidance, despite challenges in the medical surgical ...
Zacks.com on MSN
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
Medline Inc. eyes a $5B IPO to reduce debt amid strong growth in the medical disposables market. Click here to read my latest ...
The Zacks Medical - Dental Supplies industry in the Medical sector is entering the final quarter of 2025 with strong momentum ...
Zacks Investment Research on MSN
Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock?
Solventum SOLV is scheduled to release third-quarter 2025 results on Nov. 6, after market close. In the last reported quarter ...
() -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology ...
StockStory.org on MSN
McKesson (NYSE:MCK) Misses Q3 Revenue Estimates
Healthcare distributor and services company McKesson (NYSE:MCK) in Q3 CY2025, but sales rose 10.1% year on year to $103.2 ...
The wound wash market is valued at USD 208.1 million in 2025 and is expected to grow at a CAGR of 3.9% to reach USD 305.1 million by 2035. Bulk solution is the dominant product segment, representing ...
Abstract: Robot-assisted and computer-integrated surgery provides innovative, minimally invasive solutions to heal complex injuries and diseases. The dominant portion of these surgical interventions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results